Incyte (INCY) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -122.45% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | -8,140.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,140.38% |
| Dec 31, 2025 | -74.33% |
| Sep 30, 2025 | -223.89% |
| Jun 30, 2025 | -108.83% |
| Mar 31, 2025 | 101.50% |
| Dec 31, 2024 | 86.11% |
| Sep 30, 2024 | 322.67% |
| Jun 30, 2024 | 2,978.18% |
| Mar 31, 2024 | -156.00% |
| Dec 31, 2023 | -638.81% |
| Sep 30, 2023 | 39.48% |
| Jun 30, 2023 | 40.47% |
| Mar 31, 2023 | -70.52% |
| Dec 31, 2022 | 68.34% |
| Sep 30, 2022 | 13.29% |
| Jun 30, 2022 | 74.61% |
| Mar 31, 2022 | 71.97% |
| Dec 31, 2021 | 35.71% |
| Sep 30, 2021 | -126.62% |
| Jun 30, 2021 | -13.61% |
| Mar 31, 2021 | 44.96% |
| Dec 31, 2020 | -242.11% |
| Sep 30, 2020 | -217.66% |
| Jun 30, 2020 | 4.18% |
| Mar 31, 2020 | -341.97% |
| Dec 31, 2019 | 16.81% |
| Sep 30, 2019 | 168.72% |
| Jun 30, 2019 | -1,051.12% |
| Mar 31, 2019 | 13.90% |
| Dec 31, 2018 | 74.76% |
| Sep 30, 2018 | 42.03% |
| Jun 30, 2018 | 89.49% |
| Mar 31, 2018 | 79.45% |
| Dec 31, 2017 | -297.10% |
| Sep 30, 2017 | -209.88% |
| Jun 30, 2017 | 82.67% |
| Mar 31, 2017 | -582.73% |
| Dec 31, 2016 | -695.14% |
| Sep 30, 2016 | 34.59% |
| Jun 30, 2016 | -706.57% |
| Mar 31, 2016 | 149.09% |
| Dec 31, 2015 | -28.74% |
| Sep 30, 2015 | 74.08% |
| Jun 30, 2015 | 6.49% |
| Mar 31, 2015 | -22.83% |
| Dec 31, 2014 | 82.35% |
| Sep 30, 2014 | -5,751.55% |
| Jun 30, 2014 | -81.78% |
| Mar 31, 2014 | -6,191.16% |
| Dec 31, 2013 | -3,886.80% |
| Sep 30, 2013 | -302.81% |
| Jun 30, 2013 | -1,625.49% |
| Mar 31, 2013 | -130.40% |
| Dec 31, 2012 | 56.10% |
| Sep 30, 2012 | 70.39% |
| Jun 30, 2012 | -66.97% |
| Mar 31, 2012 | -1,470.83% |
| Dec 31, 2011 | 38.13% |
| Sep 30, 2011 | -198.36% |
| Jun 30, 2011 | -105.63% |
| Mar 31, 2011 | -99.63% |